Categories
Gland Pharma Limited — Updates, 15-05-2026: Press Release
15-05-2026 · 04:32 pm
Gland Pharma reported strong Q4 results: Revenue rose 22% to ₹1,742.8 Cr, PAT soared 97% to ₹366.7 Cr. Full-year revenue hit ₹6,430.7 Cr (up 14%), PAT ₹1,045.5 Cr (up 50%). CDMO business contributed significantly. Board proposed ₹20/share dividend.
No comments yet. Be the first to comment!